NeOnc Technologies Holdings, Inc. (NTHI)
3.19
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:45
NeOnc Technologies Holdings Total Assets (Quarterly) : 5.232M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.232M |
| March 31, 2026 | 3.330M |
| December 31, 2025 | 2.824M |
| September 30, 2025 | 4.083M |
| June 30, 2025 | 2.988M |
| March 31, 2025 | 8.442M |
| Date | Value |
|---|---|
| December 31, 2024 | 3.417M |
| September 30, 2024 | 2.744M |
| March 31, 2024 | |
| December 31, 2023 | 1.265M |
| September 30, 2023 | 0.9024M |
| December 31, 2022 | 0.7287M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| Arvinas, Inc. | 607.50M |
| Fulcrum Therapeutics, Inc. | 323.95M |
| Definium Therapeutics, Inc. | 1.113B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.76M |
| Shareholders Equity (Quarterly) | -18.53M |
| Debt to Equity Ratio | -0.0177 |
| Current Ratio | 0.1438 |
| Net Debt Paydown Yield | -0.06% |